Upgradation of GMP since independence
Kapil Bhargava, Former, Dy Drugs Controller (I) CDSCO, elaborates on India's journey in pharma sector post independence till today
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Cover Story
Down Memory Lane
Gandhi's visit to Cipla in 1939
Independence Day flag hoisting at Cipla 1947
President of India, Neelam Sanjiva Reddy…
Long-term goal of PvPI is to develop e-reporting and reporting culture among HCPs
Dr GN Singh, DCG(I) and Secretary-cum-Scientific Director, IPC and Dr V Kalaiselvan, Principal Scientific Officer, IPC, in an…
Need for constant vigilance
An analysis on the progress of India’s pharmacovigilance programme
FDD Conclave 2017: A congregation of R&D leaders
In an endeavour to encourage research and innovation in the rapidly evolving field of formulation development and drug delivery,…
Sanjeevani for AYUSH
AYUSH could be the answer to India's unmet medical needs but only if it is backed by scientific validation and credible evidence
Taking the green path
Express Pharma analyses efforts to make the formulation
development and drug discovery process more sustainable and…
Leading the pack
Kanish Malik, President, Operations, Glenmark Pharmaceuticals and SV Veerramani, Founder and Chairman, Fourrts India, explain the…
Thinking beyond medicines and products
Vivek P Adhia, Strategy Head – Climate, WRI India, Tanvi Bongale, Sr Project Associate, Climate, WRI India, Shruti Karkhedkar, Air…
We are collaborating with pharma companies worldwide to adopt eco-friendly methods
Over the years, Ideal Cures’ R&D department has helped pharma companies to adopt eco-friendly methods and increase…